Diagnosing peRipheral Lung Lesions With CRYO Biopsies
Launched by ODENSE UNIVERSITY HOSPITAL · Feb 19, 2025
Trial Information
Current as of July 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The DR CRYO study is looking at a new way to diagnose lung cancer by comparing two methods of obtaining tissue samples from small lung lesions. Lung cancer is a serious illness, and it's important to get an accurate diagnosis to determine the best treatment. This trial will test a technique called cryo biopsy, which uses a special tool to freeze a small piece of lung tissue for testing. This method may provide larger samples than the traditional forceps biopsy, potentially leading to better diagnoses.
To participate in this study, individuals must be at least 18 years old and undergoing tests for lung cancer due to a lung lesion that is surrounded by normal lung tissue, as seen on a CT scan. Participants will undergo a bronchoscopy, a procedure where a thin tube is inserted into the lungs to collect samples. Importantly, this study is not yet recruiting participants, but it aims to improve how doctors diagnose lung cancer by providing better tissue samples for analysis, which could help in identifying the best treatment options.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • - Patients undergoing diagnostic work-up for lung cancer due to a lung lesion surrounded by normal lung tissue (identified by CT)
- • Age 18 or above
- • Bronchoscopy with planned forceps sampling from the lesion
- Exclusion Criteria:
- • - Pregnancy
- • Not able to provide informed consent.
About Odense University Hospital
Odense University Hospital is a leading academic medical center located in Denmark, dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital is committed to enhancing patient outcomes and fostering collaboration among multidisciplinary teams. With a focus on translating scientific discoveries into practical applications, Odense University Hospital leverages its state-of-the-art facilities and expertise to conduct rigorous trials across various medical fields, ensuring adherence to the highest ethical and regulatory standards. Through these efforts, the hospital aims to contribute significantly to the global body of medical knowledge and improve the quality of care for patients both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Odense, Southern Denmark, Denmark
Næstved, Region Zealand, Denmark
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported